TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32057976

Group type: EXPERIMENTAL
Intervention: SOC-guided laser lithotripsy (SOC-LL)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Large balloon sphincteroplasty (LBS)
Number of subjects: 66
Study: 35441943

Group type: EXPERIMENTAL
Intervention: Multi-orifice epidural catheter (group E)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Conventional application (group C)
Number of subjects: 100
Study: 32761047

Group type: EXPERIMENTAL
Intervention: Tooth-bone-borne (TBB) rapid maxillary expansion
Number of subjects: 52

Group type: COMPARATOR
Intervention: Tooth-borne (TB) rapid maxillary expansion
Number of subjects: 52
Study: 33872957

Group type: EXPERIMENTAL
Intervention: Attention Training Technique (ATT)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Control intervention
Number of subjects: 78
Study: 35571974

Group type: EXPERIMENTAL
Intervention: Fecal microbiota transplantation (FMT), provided monthly for up to six months
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Fecal microbiota transplantation (FMT)
Number of subjects: 9
Study: 35201924

Group type: EXPERIMENTAL
Intervention: Foot reflexology (30 minutes twice per week for 6 weeks)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Warm foot-bath (1 hour before bedtime every evening for 6 weeks)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Foot reflexology
Number of subjects: 100

Group type: COMPARATOR
Intervention: Warm foot-bath
Number of subjects: 100
Study: 32212932

Group type: EXPERIMENTAL
Intervention: Expert recommendations (attainable)
Number of subjects: 345

Group type: EXPERIMENTAL
Intervention: Peer information (less attainable)
Number of subjects: 345

Group type: COMPARATOR
Intervention: No-feedback control
Number of subjects: 345
Study: 35349976

Group type: EXPERIMENTAL
Intervention: High-dose minocycline (10 mg/kg)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 11
Study: 33453782

Group type: EXPERIMENTAL
Intervention: PRAISE score (machine learning-based risk stratification model)
Number of subjects: 19826
Study: 35349953

Group type: EXPERIMENTAL
Intervention: PIO-5 (5 mg PIO/bird/day)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: PIO-10 (10 mg PIO/bird/day)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control (basal diet)
Number of subjects: 24
Study: 36415112

Group type: EXPERIMENTAL
Intervention: Berberine triple therapy (berberine, amoxicillin, rabeprazole)
Number of subjects: 524

Group type: COMPARATOR
Intervention: Standard bismuth quadruple therapy (amoxicillin, rabeprazole, clarithromycin, bismuth tartrate)
Number of subjects: 524
Study: 32654080

Group type: EXPERIMENTAL
Intervention: All urate-lowering therapies (ULTs)
Number of subjects: 7968

Group type: EXPERIMENTAL
Intervention: Febuxostat 80/120/240 mg/day
Number of subjects: 7968

Group type: EXPERIMENTAL
Intervention: Lesinurad in combination with febuxostat or allopurinol
Number of subjects: 7968

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7968
Study: 33478875

Group type: EXPERIMENTAL
Intervention: Water-slider method (WSM)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional suction retrieval (non-WSM)
Number of subjects: 0
Study: 35325258

Group type: EXPERIMENTAL
Intervention: HARPdoc cohort
Number of subjects: 99

Group type: COMPARATOR
Intervention: Comparator group (n=81)
Number of subjects: 99
Study: 34636463

Group type: EXPERIMENTAL
Intervention: Djulis functional drinks (50 ml daily for 8 weeks)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo drinks (50 ml daily for 8 weeks)
Number of subjects: 30
Study: 34103473

Group type: EXPERIMENTAL
Intervention: High-dose hUC-MSC (1.5 × 10^6/kg body weight)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Low-dose hUC-MSC (0.5 × 10^6/kg body weight)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Low-dose hUC-MSC
Number of subjects: 72
Study: 32333337

Group type: EXPERIMENTAL
Intervention: Photobiomodulation therapy (PBM) - 24 sessions, 810 nm, 5 diodes × 200 mW, 30 J/application site
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control group (CG) - no physical therapy intervention, only underwent hemodialysis (HD) sessions
Number of subjects: 28
Study: 32700100

Group type: EXPERIMENTAL
Intervention: Laparoscopic anti-reflux surgery (LARS)
Number of subjects: 25
Study: 35391541

Group type: EXPERIMENTAL
Intervention: SOC + GCSF at 10 ug/kg in 3 daily doses within 4 days of Kasai
Number of subjects: 218

Group type: EXPERIMENTAL
Intervention: SOC + GCSF
Number of subjects: 218

Group type: COMPARATOR
Intervention: SOC + NO-GCSF
Number of subjects: 218
Study: 34797293

Group type: EXPERIMENTAL
Intervention: Danhong injection
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 32608055

Group type: EXPERIMENTAL
Intervention: Clinical assessments (including BMI, pain duration, repeated single step-ups to pain onset)
Number of subjects: 179

Group type: EXPERIMENTAL
Intervention: Multivariate logistic regression analysis
Number of subjects: 179
Study: 35460070

Group type: COMPARATOR
Intervention: Cytology (Cytology Arm) at 24-month intervals
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: HPV-based screening (HPV Arm) at 48-month intervals
Number of subjects: 111
Study: 32134290

Group type: EXPERIMENTAL
Intervention: OurRelationship program
Number of subjects: 742

Group type: EXPERIMENTAL
Intervention: ePREP program
Number of subjects: 742

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 742
Study: 32109883

Group type: EXPERIMENTAL
Intervention: Regular dribble (RD)
Number of subjects: 10

Group type: COMPARATOR
Intervention: No dribble (ND)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 3 vs 3 format
Number of subjects: 10

Group type: COMPARATOR
Intervention: 5 vs 5 format
Number of subjects: 10

Group type: COMPARATOR
Intervention: 4 vs 4 format
Number of subjects: 10
Study: 35030634

Group type: EXPERIMENTAL
Intervention: Tisagenlecleucel (JULIET study)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Historical treatments (CORAL study)
Number of subjects: 0
Study: 32036482

Group type: EXPERIMENTAL
Intervention: 0.2% Hilyses supplementation
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: 0.4% Hilyses supplementation
Number of subjects: 270

Group type: COMPARATOR
Intervention: Control group (basal diet)
Number of subjects: 270
Study: 35502773

Group type: COMPARATOR
Intervention: Not available
Number of subjects: 0
Study: 33368290

Group type: EXPERIMENTAL
Intervention: Cr-yeast
Number of subjects: 540

Group type: EXPERIMENTAL
Intervention: CrMet
Number of subjects: 540

Group type: EXPERIMENTAL
Intervention: CrNic
Number of subjects: 540
Study: 36480560

Group type: EXPERIMENTAL
Intervention: Rosuvastatin (20 mg/day) for 6 months
Number of subjects: 84

Group type: COMPARATOR
Intervention: Control (statin non‐users)
Number of subjects: 84
Study: 34003226

Group type: EXPERIMENTAL
Intervention: Lanthanum Carbonate
Number of subjects: 2374

Group type: COMPARATOR
Intervention: Calcium Carbonate
Number of subjects: 2374
Study: 32901778

Group type: EXPERIMENTAL
Intervention: Home telemonitoring system (IN group)
Number of subjects: 154

Group type: COMPARATOR
Intervention: Standard care (OUT group)
Number of subjects: 154
Study: 35610318

Group type: EXPERIMENTAL
Intervention: Continuous infusion with loading dose group (GpIII)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Continuous infusion without loading dose group (GpII)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Intermittent group (GpI)
Number of subjects: 48
Study: 34243738

Group type: EXPERIMENTAL
Intervention: PathMate2 group (PM) - daily conversational agent counselling via mobile app, combined with standardized counselling (4 on-site visits) for 5.5 months.
Number of subjects: 41

Group type: COMPARATOR
Intervention: Control group (CON) - multi-component behaviour changing intervention (BCI) with 7 on-site visits for 5.5 months.
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Biofeedback relaxation exercises (part of the intervention for both groups).
Number of subjects: 41
Study: 33278291

Group type: EXPERIMENTAL
Intervention: 0.25% bupivacaine with 4 mg dexamethasone
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: 0.25% bupivacaine
Number of subjects: 75

Group type: COMPARATOR
Intervention: 0.9% saline (placebo)
Number of subjects: 75
Study: 32267989

Group type: EXPERIMENTAL
Intervention: Spinal cord stimulation (SCS) trial duration >10 days
Number of subjects: 174

Group type: COMPARATOR
Intervention: Spinal cord stimulation (SCS) trial duration ≤10 days
Number of subjects: 174

Group type: EXPERIMENTAL
Intervention: Trial duration median 21 days for those with infection
Number of subjects: 174

Group type: EXPERIMENTAL
Intervention: Trial duration median 21.5 days in Belgium
Number of subjects: 174

Group type: COMPARATOR
Intervention: Trial duration median 5.8 days in other countries
Number of subjects: 174
Study: 36414947

Group type: EXPERIMENTAL
Intervention: Omega-3 supplementation (1000 mg natural fish oil soft-gels daily for 3 months)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Soybean oil soft-gels (control group)
Number of subjects: 30
Study: 32072879

Group type: EXPERIMENTAL
Intervention: Self-referencing messages in a narrative
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: Self-referencing messages highlighting health risks of obesity
Number of subjects: 146
Study: 34120898

Group type: COMPARATOR
Intervention: Donepezil
Number of subjects: 2198
Study: 32114875

Group type: EXPERIMENTAL
Intervention: Proximal axillary vein approach
Number of subjects: 99

Group type: COMPARATOR
Intervention: Distal axillary vein approach
Number of subjects: 99
Study: 34406366

Group type: EXPERIMENTAL
Intervention: Oral abrocitinib 200 mg
Number of subjects: 285

Group type: EXPERIMENTAL
Intervention: Oral abrocitinib 100 mg
Number of subjects: 285

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 285

Group type: EXPERIMENTAL
Intervention: Adverse events
Number of subjects: 285
Study: 33325757

Group type: EXPERIMENTAL
Intervention: MenACWY-CRM
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: MenC-CRM
Number of subjects: 90
Study: 34267582

Group type: EXPERIMENTAL
Intervention: 15 Hz vibration
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: 5 Hz vibration
Number of subjects: 19

Group type: COMPARATOR
Intervention: 0 Hz vibration (control)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Low-frequency lower-body vibration (LBV)
Number of subjects: 19
Study: 32172686

Group type: EXPERIMENTAL
Intervention: Spiritual coping through adherence measures (interview or daily phone diary)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Spiritual constructs
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Qualitative analysis of spirituality's role
Number of subjects: 25
Study: 35398306

Group type: EXPERIMENTAL
Intervention: Primary implantation of an intraocular lens (IOL)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Contact lens correction after being left aphakic
Number of subjects: 0
Study: 33452288

Group type: EXPERIMENTAL
Intervention: Anodal tDCS
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Cathodal tDCS
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham (placebo) tDCS
Number of subjects: 30

Group type: COMPARATOR
Intervention: Comparison of tDCS groups vs. Sham
Number of subjects: 30
Study: 35303094

Group type: EXPERIMENTAL
Intervention: Active cathodal HD tDCS targeting left IFG
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Active cathodal HD tDCS targeting left DLPFC
Number of subjects: 67
Study: 32588238

Group type: EXPERIMENTAL
Intervention: Standard-duration DAPT (≥ 12 months)
Number of subjects: 5131

Group type: COMPARATOR
Intervention: Short-duration DAPT (≤ 6 months)
Number of subjects: 5131
Study: 32481332

Group type: EXPERIMENTAL
Intervention: Tong Jing Tiao Xing tuina (TJTX) once a day, Excising with scalp acupuncture (ESA) once a day, and oral Yinao fujian formula (YNFJ) twice a day for 5 sessions a week for 4 weeks.
Number of subjects: 316

Group type: COMPARATOR
Intervention: Physical therapy (PT) for 5 sessions a week for 4 weeks.
Number of subjects: 316
Study: 36196767

Group type: EXPERIMENTAL
Intervention: Sonazoid-enhanced ultrasound (SZUS)
Number of subjects: 105

Group type: COMPARATOR
Intervention: SonoVue-enhanced ultrasound (SVUS)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Sonazoid-enhanced ultrasound (SZUS) with 5-minutes washout criterion
Number of subjects: 105

Group type: COMPARATOR
Intervention: SonoVue-enhanced ultrasound (SVUS) with 5-minutes washout criterion
Number of subjects: 105
Study: 32354671

Group type: EXPERIMENTAL
Intervention: Promotion of HPV vaccination
Number of subjects: 278

Group type: COMPARATOR
Intervention: Promotion of healthy eating and appropriate nutrition label interpretation
Number of subjects: 278
Study: 34590545

Group type: EXPERIMENTAL
Intervention: Tandem-based standing on foam with an externally focused dual-task (TBFE)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Baseline single task (TBF)
Number of subjects: 32
Study: 33040491

Group type: EXPERIMENTAL
Intervention: Ferric carboxymaltose (FCM)
Number of subjects: 53
Study: 33922576

Group type: EXPERIMENTAL
Intervention: High dose strawberry powder (32 g/day)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Low dose strawberry powder (13 g/day)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control powder
Number of subjects: 33
Study: 35399845

Group type: EXPERIMENTAL
Intervention: Meloxicam combined with warm acupuncture (JG)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Meloxicam (CG)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Warm acupuncture (TCMG)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: All groups (JG, CG, TCMG)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Improvement time of clinical symptoms (JG, CG, TCMG)
Number of subjects: 81
Study: 34265850

Group type: EXPERIMENTAL
Intervention: Music training
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Foreign language training
Number of subjects: 123

Group type: COMPARATOR
Intervention: Passive control group
Number of subjects: 123
Study: 35760423

Group type: EXPERIMENTAL
Intervention: User centered clinical decision support tool
Number of subjects: 5047

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 5047
Study: 32347137

Group type: EXPERIMENTAL
Intervention: Support Vector Machine (SVM) algorithm with linear kernel function applied to training data
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Support Vector Machine (SVM) algorithm with linear kernel function applied to test set
Number of subjects: 210
Study: 36037286

Group type: EXPERIMENTAL
Intervention: 3D-printed medial arch support A
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 3D-printed medial arch support B
Number of subjects: 12

Group type: COMPARATOR
Intervention: Prefabricated arch support C
Number of subjects: 12
Study: 33358162

Group type: EXPERIMENTAL
Intervention: Filter bags (F57)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Loose powder (LS)
Number of subjects: 18
Study: 32004568

Group type: EXPERIMENTAL
Intervention: Bermekimab (400 mg weekly for 13 doses) in anti-TNF naïve patients (n = 18)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Bermekimab (400 mg weekly for 13 doses) in patients who failed anti-TNF therapy (n = 24)
Number of subjects: 42
Study: 35580634

Group type: EXPERIMENTAL
Intervention: Oral phenazopyridine (200 mg taken 1 to 2 hours preprocedure)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Intravesical lidocaine (20-minute instillation of 50 mL of 2% lidocaine)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Provider perception of participant comfort and overall ease of procedure
Number of subjects: 100

Group type: COMPARATOR
Intervention: Length of time in the exam room
Number of subjects: 100

Group type: COMPARATOR
Intervention: Cystoscopic visualization
Number of subjects: 100
Study: 32255549

Group type: EXPERIMENTAL
Intervention: MW01-6-189WH (MW189)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 32141476

Group type: EXPERIMENTAL
Intervention: Bipolar mobile Application (Bip.App)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Group Psychoeducation (PE)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination of Bip.App and Group PE
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bip.App
Number of subjects: 0
Study: 35421984

Group type: EXPERIMENTAL
Intervention: Nasal balloon autoinflation
Number of subjects: 340

Group type: COMPARATOR
Intervention: No nasal balloon autoinflation (Control)
Number of subjects: 340
Study: 35317665

Group type: EXPERIMENTAL
Intervention: Verum acupuncture
Number of subjects: 144

Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 144
Study: 32873287

Group type: EXPERIMENTAL
Intervention: UNICEF/Washington Group Child Functioning Module (CFM)
Number of subjects: 1439

Group type: COMPARATOR
Intervention: Modified Washington Group short set (mWG-SS)
Number of subjects: 1439
Study: 35802142

Group type: EXPERIMENTAL
Intervention: Tadalafil 5 mg OD
Number of subjects: 140

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 140
Study: 33588084

Group type: EXPERIMENTAL
Intervention: Healthy dietary pattern
Number of subjects: 392

Group type: EXPERIMENTAL
Intervention: Mediterranean dietary pattern
Number of subjects: 392

Group type: EXPERIMENTAL
Intervention: Western dietary pattern
Number of subjects: 392

Group type: EXPERIMENTAL
Intervention: Vegetable dietary pattern
Number of subjects: 392
Study: 33036201

Group type: EXPERIMENTAL
Intervention: Partially hydrolyzed whey infant formula (PHF)
Number of subjects: 142

Group type: COMPARATOR
Intervention: Standard infant formula with intact protein (IPF)
Number of subjects: 142
Study: 34052908

Group type: EXPERIMENTAL
Intervention: SSGT KONTAKT® (n = 46)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Active control (manualised interactive group cooking programme, n = 44)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: SSGT KONTAKT®
Number of subjects: 90
Study: 33827421

Group type: COMPARATOR
Intervention: Sodium valproate (group A)
Number of subjects: 222

Group type: EXPERIMENTAL
Intervention: Concurrent magnesium with sodium valproate (group B)
Number of subjects: 222

Group type: COMPARATOR
Intervention: Magnesium (group C)
Number of subjects: 222
Study: 36038015

Group type: EXPERIMENTAL
Intervention: Very Low Nicotine Content (VLNC) cigarettes (0.2 mg nicotine/cigarette)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual Nicotine Content (UNC) cigarettes (11.6 mg nicotine/cigarette)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: VLNC cigarettes in the gradual nicotine reduction arm for non-menthol smokers
Number of subjects: 0
Study: 34883808

Group type: EXPERIMENTAL
Intervention: ICAGD coronoplasty
Number of subjects: 100

Group type: COMPARATOR
Intervention: Tooth polishing
Number of subjects: 100
Study: 35759325

Group type: EXPERIMENTAL
Intervention: Therapeutic adherence and competence scale for grief (TACs-G)
Number of subjects: 48
Study: 32365981

Group type: EXPERIMENTAL
Intervention: Lactobacillus plantarum 299v with 20 mg of iron
Number of subjects: 53

Group type: COMPARATOR
Intervention: 20 mg of iron alone
Number of subjects: 53
Study: 35410241

Group type: EXPERIMENTAL
Intervention: mySugr PRO (digital self-management application)
Number of subjects: 466

Group type: COMPARATOR
Intervention: Control group (no usage of the application)
Number of subjects: 466
Study: 34078314

Group type: EXPERIMENTAL
Intervention: Daratumumab plus bortezomib/melphalan/prednisone (D-VMP)
Number of subjects: 0

Group type: COMPARATOR
Intervention: VMP alone
Number of subjects: 0
Study: 32389050

Group type: EXPERIMENTAL
Intervention: Precontoured lateral locking plate fixation with interfragmentary lag screws
Number of subjects: 76

Group type: COMPARATOR
Intervention: Precontoured lateral locking plate fixation without interfragmentary lag screws
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Both groups (with and without lag screws)
Number of subjects: 76
Study: 35761383

Group type: EXPERIMENTAL
Intervention: Ketoprofen 100 mg per os 2 hours before surgery
Number of subjects: 144

Group type: COMPARATOR
Intervention: Starch tablet per os 2 hours before surgery (control group)
Number of subjects: 144
Study: 34011111

Group type: EXPERIMENTAL
Intervention: Cognitive behavioral intervention
Number of subjects: 140

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 140
Study: 32197636

Group type: EXPERIMENTAL
Intervention: Adjunct low-dose continuous infusion of ketamine (2 μg/kg/min for the first 24 hours, then 1 μg/kg/min for the second 24 hours) plus standard of care.
Number of subjects: 80

Group type: COMPARATOR
Intervention: Standard of care (propofol and/or fentanyl and/or midazolam) according to the KFSH&RC sedation and analgesia protocol.
Number of subjects: 80
Study: 36134443

Group type: EXPERIMENTAL
Intervention: App-guided fluid therapy calculations
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: App-guided integrated fluid therapy plans
Number of subjects: 55

Group type: COMPARATOR
Intervention: Conventional method
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Preference for app-guided method
Number of subjects: 55
Study: 32858228

Group type: EXPERIMENTAL
Intervention: Vitamin D 2000 IU/day
Number of subjects: 2157

Group type: EXPERIMENTAL
Intervention: Omega-3 fatty acids 1000 mg/day (EPA+DHA, ratio 1:2)
Number of subjects: 2157

Group type: EXPERIMENTAL
Intervention: 30-minute home exercise 3 times/week (strength versus flexibility)
Number of subjects: 2157

Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 2157
Study: 35614848

Group type: EXPERIMENTAL
Intervention: Dietary carbohydrate intake
Number of subjects: 547

Group type: EXPERIMENTAL
Intervention: Dietary fibre and glycaemic index
Number of subjects: 547
Study: 32014055

Group type: EXPERIMENTAL
Intervention: hUC‐MSC transplantation (four transfusions intravenously)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: hUC‐MSC transplantation
Number of subjects: 39
Study: 33201154

Group type: EXPERIMENTAL
Intervention: Normal sleeve (NS)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Tighter sleeve (TS)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control sleeve (CS)
Number of subjects: 15
Study: 32527389

Group type: EXPERIMENTAL
Intervention: Alcohol dose of .04 g/dl
Number of subjects: 184

Group type: EXPERIMENTAL
Intervention: Alcohol dose of .065 g/dl
Number of subjects: 184

Group type: EXPERIMENTAL
Intervention: Alcohol doses (.04 g/dl and .065 g/dl)
Number of subjects: 184
Study: 34303355

Group type: EXPERIMENTAL
Intervention: Trial of labor after cesarean section (TOLAC)
Number of subjects: 778

Group type: EXPERIMENTAL
Intervention: Nomogram prediction model based on multiple logistic regression analysis
Number of subjects: 778

Group type: EXPERIMENTAL
Intervention: Factors associated with successful TOLAC
Number of subjects: 778